As the broader economy ping pongs between state lockdowns, unemployment reports and escalating public markets, COVID-19 still down't appear to have torpedoed investors' interests in digital health.
During the second quarter of 2020, MobiHealthNews tracked 89 funding deals totaling $2.44 billion – a slight increase in volume but decline in value when compared to both Q2 2019 (81 deals, $2.45 billion) and Q1 2020 (82 deals, $2.9 billion). That broader spread of funds isn't to say that there weren't some heavy-hitting deals this quarter, as startups focused on insurtech, telehealth, artificial intelligence drug discovery, and tech-enabled home care all took home nine-figure investments.
See below for the full list of funding announcements reported by MobiHealthNews this quarter, along with links to their associated news stories.
| Company | Round/Series | Amount (M) | Investors | What's it for | What they do |
| Oscar Health | Series C | $225 | Alphabet, General Catalyst, Khosla Ventures, Lakestar, Thrive Capital and Baillie Gifford | The company is planning to use this latest infusion of cash to expand its footprint. |
Oscar offers direct-to-consumer health insurance. Currently it has plans for individuals and families, businesses, and Medicare Advantage plans.
|
| Amwell | Series C | $194 | Allianz X and Takeda | The company plans to use the new money to help expand its technology and services and help providers scale. |
Amwell is among the largest consumer and enterprise telehealth providers.
|
| insitro | Series B | $143 | Andreessen Horowitz, Canada Pension Plan Investment Board, T. Rowe Price Associates, BlackRock, Casdin Capital, HOF Capital, WuXi AppTec's Corporate Venture Fund, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, and Alexandria Venture Investments | The funds will support the continued construction of its technology, and allow it to begin pursuing genetically validated targets and therapeutics among certain patient populations. |
insitro analyzes genetic, phenotypic and clinical data to find likely candidates for new treatments.
|
| DispatchHealth | Series C | $135.80 | Optum Ventures, Alta Partners, Questa Capital, Echo Health Ventures, Oak HC/FT and Humana. | With these funds, DispatchHealth plans to grow its services in cities they already occupy and into new locations. It also will begin offering additional services available on its platform. |
Patients and their providers can request services by calling in by phone – or via the mobile app or website. A team of medical professionals is then sent to the patient’s house within two hours of the request to provide the necessary care.
|
| Cedar | Series C | $102.00 | led by Andreessen Horowitz. | The company said the new funds will be put towards expanding its overall offerings. |
The company focuses on helping to guide patients through their medical bills and payments.
|
| Mindstrong | Series C | $100 | Undisclosed | The company plans to use the latest funds to scale its business. |
Mindstrong's digital mental health platform combines telehealth, care management and digital biomarkers.
|
| Cue Health | Series C | $100.00 | Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and other unnamed investment firms all participated in the raise. | The new funds will be used to scale the manufacturing of its platform. |
Cue is a rapid diagnostics startup now working on a connected testing device.
|
| LetsGetChecked | Series C | $71 | Illumina Ventures, HLM Venture Partners, Deerfield, CommonFund Capital and Angeles Investments, Transformation Capital, Optum Ventures and Qiming Venture Partners USA | The company said these funds will help build up its manufacturing, supply and testing capacity for COVID-19. |
LetsGetChecked provides consumer customers with a range of at-home testing kits, such as ones for hormone levels, sexually transmitted infections, liver performance, nutrition and COVID-19.
|
| Aledade | Series C | $64 | OMERS Growth Equity, California Medical Association, Meritech Capital, Echo Health Ventures, CVF and GV | The funds will help it to continue growing new and existing ACOs in addition to value-based contracts with public and commercial health plans. |
Aledade partners with providers to build tech-enabled accountable care organizations.
|
| Exscientia | Series C | $60 | Novo Holdings, Evotec, Bristol Myers Squibb and GT Healthcare Capital Partners | The money will expand the various projects in Exscientia's portfolio and pipeline, and help it launch new efforts. |
Exscientia has a platform that uses AI to design novel compounds for synthesis and clinical development.
|
| Patient Ping | Series C | $60 | Andreessen Horowitz, F-Prime Capital, GV, and Transformation Capital led the round with participation from existing investors. | The latest funding, which actually closed a year ago but was no announced until recently, is expected to help the company expand its geographical footprint and reach to move providers. |
The company is able to coordinate patient care by giving a notification to providers when a patient receives care at another institution.
|
| Alan | Series C | $54.30 | Temasek and Index Ventures | The company aims to launch additional services like these while expanding out of France into the rest of Europe. |
Alan's health insurance platform looks to provide users with access to providers, information and other care support via its app.
|
| Dascena Inc. | Series B | $50 | Frazier Healthcare Partners, Longitude Capital, Euclidean Capital and another undisclosed investor. | The round will help Dascena continue development on its suite of diagnostic machine learning algorithms for clinician decision support. |
The company's flagship product is a machine learning algorithm for sepsis.
|
| Tyto Care | N/A | $50 | Inight Partners, Olive Tree Ventures and Qualcomm Ventures | The company plans to use the new funds to expand its commercialization efforts the U.S., Europe and Asia. It is also looking at expanding its AI and machine learning home device product. |
The company is part telehealth and part remote-monitoring. It allows patients to use digital tools to help conduct their exam at home, while being guided and evaluated by a doctor via telemedicine.
|
| Headspace | Series C | $47.70 | Undisclosed | While the company did not specify what the funding was for, the add-on funding would presumably be aiming for many of the same goals Headspace outlined near the beginning of the year. |
Headspace is a mindfulness and meditation app.
|
| 98point6 | Series D | $43 | Undisclosed | The company said it will be tripling the size of its physician workforce before the end of the month to handle new demand. |
98point6 provides on-demand primary care services for consumers and health plans that can be accessed through the company's mobile app.
|
| Owkin | Series A | $43 | Mubadala Capital, Bprifrance, Cathay Innovation and MACSF | The company plans on using the new money to grow its technology. It will also go towards expanding its COVID-19 specific tool. |
Owkin is a machine learning medical research company aiming to connect doctors, researchers, scientists and other stakeholders.
|
| BrightInsight | Series B | $40 | Insight Partners headlined the raise, which also featured Series A investors New Leaf Venture Partners and Eclipse Ventures. | In addition to fueling the growth of its worldwide team, BrightInsight said it will be expanding its platform with more analytics functionalities and the launch of pre-built software assets for digital clinical trials. |
BrightInsight – a part of electronics manufacturing services firm Flex – sees itself acting as the infrastructure of a digital health ecosystem.
|
| Abacus Insights | Series B | $35 | Blue Venture Fund led the round, and was accompanied by CRV, .406 Ventures, Horizon Healthcare Services and Echo Health Ventures. | The Boston-based company will be deploying the new capital to scale its business, continue to flesh out the capabilities and connections supported by its platform, and make new hires. |
Abacus Insights, a data interoperability technology company targeting health plan customers, collected $35 million in Series B funding, bringing its lifetime venture backing to $53 million.
|
| Higi | N/A | $30 | Babylon Health, 7Wire Ventures, Flare Capital Partners, Jumpstart Capital, Rush University Medical Center for Health and William Wrigley Jr. | Higi will be using the funds to expand the reach and content offerings of its health kiosks, notably with the support of Babylon's tech. |
Higi's distributes in-store health kiosks equipped to administer quick tests for blood pressure, pulse, weight and BMI.
|
| Big Health | Series B | $30.00 | Gilde Health, Morningside Ventures, Samsung NEXT, Kaiser Permanente Ventures and Octopus Ventures. | The raise will support new product development, as well as growth of its distribution channels and commercialization efforts. |
Big Health's two main products Sleepio and Daylight are digital programs to help users manage poor sleep and anxiety.
|
| Kyruus | Series D | $30.00 | Francisco Partners | Kyruus plans to use the new funds to expand its platform into new health systems and in new market segments. |
The company makes a provider search and scheduling tool for health systems.
|
| Carbon Health | Series B1 | $28 | DCVC | The company said that it increased its staff from 100 employees to more than 300, and has now expanded its virtual-care service to treat patients in 15 additional states |
The San Francisco-based company runs a series of brick-and-mortar clinics in California. supported by the Carbon Health mobile app, through which patients can view their health records, schedule appointments, handle their payments or receive their care through a video telehealth visit.
|
| SonderMind | Series B | $27 | General Catalyst, F-Prime Capital, Kickstart Seed Fund, Diōko Ventures and Jonathan Bush | The new funds are expected to help the mental health startup expand its geographical footprint into Texas and Arizona, as well as ink deals with new payers, employers and health systems. |
The Denver, Colorado-based company's platform helps link up patients and therapists based on specific needs and geographic location.
|
| Nanox | N/A | $26 | SK Telcom | This new investment comes with a partnership agreement between Nanox and SK Telcom. The two companies are working together to deploy 2,500 Nanox Systems into South Korea and Vietnam. |
The company is currently working on a technology offering that combines an in-hospital scanning device with a companion cloud software tool.
|
| Vida Health | Series A | $25 | Ally Bridge Group, AME Cloud Ventures, Aspect Ventures, Canvas Ventures, NGP Capital, Webb Investment Network and Workday Ventures | The company will be using its funds to meet the growing demand for virtual care services – and in particular mental health care – triggered by COVID-19. |
Vida's approach combines live health coaches and therapists with a data-driven mobile platform.
|
| Hydrow | N/A | $25.00 | L Catterton, Rx3 Ventures and other prior backers | The company will be aiming to expand its workout content offerings, which include its mainstay rowing simulations, in addition to functional movement workouts. |
Hydrow’s consumer device delivers an in-home rowing workout supported by live or on-demand digital courses.
|
| Tia | Series A | $24 | Threshold Venture's Emily Melton, Define Ventures, ACME, Torch Capital, John Doerr, Homebrew and Compound | The company plans to use the new funds in order to build out its virtual health capabilities. |
Tia follows a hybrid model of care – it offers both brick-and-mortar services and virtual tools to patients – that exclusively focuses on women's health.
|
| Medici | Series B | $24 | Barry Sternlicht, from Starwood Capital Group; Kenneth Griffin, from Citadel; Nathan Kirsh, from the Kirsh Group; Howard Jenkins, from Publix; and Tom Meredith, formerly of Dell | Medici offered slim details on how its new funds would be spent, other than to say that the money would help accelerate its growth both during and after the COVID-19 crisis. |
Medici's mobile platform is a telehealth service bolstered by a range of messaging and billing features.
|
| PlushCare | Series B | $23.00 | Transformation Capital led the round, which included GGV Capital, WTI and other unnamed individual investors. | The company said that the raise would help accelerate its development road map and fuel growth. |
PlushCare's platform connects consumers across all 50 U.S. states to an online video visit with a doctor.
|
| Holmusk | Series A | $22 | Optum Ventures, Health Catalyst Capital, Heritas Capital and other individuals | The new funding round allows Holmusk to expand its US operations, and supports investment in its proprietary technology. |
Holmusk's real-world evidence platform helps customers accelerate drug development and data-driven medcine.
|
| Nanit | N/A | $21 | Jerusalem Venture Partners, Upfront Ventures, RRE Ventures and Rho Capital Partners | The company plans to use the new funds to expand its product line and global footprint. |
Nanit specializes in tracking infants' sleep and breathing with a smart camera system and app.
|
| RapidSOS | N/A | $21.00 | Transformation Capital, C5 Capital, Laerdal Million Lives Fund and existing investors | The company plans to use the money to extend the work it is currently doing. I |
The company developed its digital platform to provide free critical data to first responders in order to make faster and smarter emergency responses.
|
| CyberMDX | N/A | $20 | Sham (Relyens Group), Pitango Venture Capital and Qure Ventures | In addition to tech platform and research investments, the CyberMDX will be pushing its geographic expansion and go-to-market efforts with these new funds. |
The company deploys healthcare cybersecurity software to a provider's network, where it identifies and protects the organization's connected medical devices, IT systems and other internet of things. devices.
|
| Ubie | Series B | $19 | Suzuken | The startup will use the fresh funds to scale up the use of its healthtech platforms, expand research and development capabilities, and staff its various sales and engineering teams. |
The Ubie for Hospital product is an AI-driven medical questionnaire software targeting users at medical institutions, in order to support document creation of clinical records under supervision from specialists.
|
| Ezra | Series A | $18 | FirstMark Capital, Accomplice, Seedcamp, Credo Ventures, Founders Future, LDV Capital, Jeff Raider, Dave Gilboa, Vlad Tenev, Fred Destin Andrei Dunca, Esther Dyson, Taavet Hinrikus, Daniel Dines, Dave McClure, and Jeremy Arditi | The New York tech company said that it aims to expand its collection of medical-imaging AI tools with the new funds. |
Ezra is a medical imaging and AI startup targing cancer.
|
| Cyclica | Series B | $16.90 | Drive Capital, Chiesi Farmaceutici, GreenSky Capital and members of Cyclica's management team | The new funds would support Cyclica's integrated proteome-wide drug-discovery platform, fuel expansion into adjacent sectors such as agrochemicals and broadly accelerate its commercial strategy. |
Cyclica is an AI drug discovery platform.
|
| Bright.md | Series C | $17 | B Capital, Seven Peaks Ventures, Concord Health Partners, Philips Health Technology Ventures and UnityPoint Health Ventures | The startup will be ramping up its technology offerings and increasing market expansion efforts with the new funds. |
Bright.md's primary offering is SmartExam, which it describes as the "virtual front door" for patients seeking care.
|
| Lifesprk | Series A | $16 | Virgo Investment Group | The funds will help Lifesprk invest in new technologies to support its Life Experience Alternative Delivery System (LEADS). |
Lifesprk is a senior-care company that uses a prioprietary tech system to coordinate care.
|
| Scopio Labs | Series B | $16 | Olive Tree Venture, Aurum Ventures, OurCrowd, LR Group and others | Scopio is using the raise to further its manufacturing and sales efforts, as well as to further develop its clinical trial pipeline. |
The Israeli company looks to automate imaging of full microscopy samples into digital scans, and offers a platform that includes remote-consultation support.
|
| SilverCloud | Series B | $16.00 | MemorialCare Innovation Fund, LRVHealth, OSF Ventures and UnityPoint Health Ventures | The new money will go into growing SilverCloud and expanding its services. |
The company works with provider organizations to deliver dozens of digital mental health programs.
|
| NexHealth | Series A | $15 | Individual investors | NexHealth is aiming to grow its API offering with the new funds. |
The startup offers an interoperable online healthcare appointment system with telehealth, messaging, payment processing and other features.
|
| Augmedics | Series B | $15.00 | Augmedics' US staff, AO Invest, Terralab Ventures and undisclosed investors | Augmedics plans to explore how it can integrate the xvision technology into other surgical applications. |
The company develops augmented reality surgical image guidance tools.
|
| RDMD | Series A | $14 | Spark Capital, Lux Capital, Village Global, Garuda Ventures, Maveron Capital and a collection of angel investors | The company's plans include expansions into 20 more rare diseases, new research study launches for these conditions, collaborative partnerships and team hires. |
RDMD employs personal health records to accelerate rare disease drug research.
|
| Binah.ai | Series B | $13.50 | Maverick Ventures Israel headlined the round, while prior backers Esplanade Ventures, Sompo International, GiTV and iAngels also participated. | The Tel Aviv, Israel-based company said that it's looking to boost its sales and marketing efforts with the new funds. |
Its platform currently provides measurements of heart rate, heart rate variability, oxygen saturation and respiration rate, with plans in the works to add blood pressure, hemoglobin, temperature and more.
|
| Particle Health | Series A | $12 | Menlo Ventures, Collaborative Fund, Story Ventures, Company Ventures and individual backers | The company did not disclose its plans for the funds. |
Particle Health offers digital health stakeholders such as telemedicine providers or pharmacies an API that securely and quickly pulls patient records.
|
| Conversa Health | Series B | $12.00 | Builders VC, Northwell Ventures, P5 Health Ventures, Nassau Street Ventures and UH Ventures | Conversa plans to use this additional funding to scale its communication platform. |
The company makes an automated virtual care communication platform.
|
| Siren | Series B | $11.80 | Anathem Ventures, DCM, Khosla Ventures, 500 Startups and Peter Thiel’s Founders Fund | The company did not disclose its plans for the new funds. |
The company has developed temperature-monitoring socks that can communicate with a software application.
|
| Navenio | Series A | $11 | QBN Capital, G.K. Goh, Hostplus, Big Pi Ventures, Oxford Investment Consultants, Oxford Sciences Innovation (OSI), IP Group plc and the University of Oxford | The funds will be used to increase the scope of Navenio’s offering in the UK, as well as in the US and Asia, where it has a number of evolving partnerships. |
Navenio provides infrastructure-free indoor location solutions to power a range of apps and platforms in sectors including healthcare.
|
| VIDA Diagnostics | Series C | $11 | First Analysis Corporation, Blue Heron Capital, UnityPoint Health Ventures, Next Level Ventures, Chartline Capital Partners, the Rural Vitality Fund, Rittenhouse Ventures, Iowa First Capital Fund and the Angels' Forum | VIDA Diagnostics will be expanding the clinical portfolio of its platform. |
The company offers an AI-powered lung imaging analysis platform called LungPrint.
|
| Wellth | Series A | $10 | Yabeo, Boehringer Ingelheim Venture Fund, AXA Venture Partners, New York Life Ventures, NFP Ventures, I2BF Global Ventures, the Partnership Fund for New York City, Rock Health, DaVita Venture Group | The company said that it will be using the funds to scale its platform so that it can support more substantial patient populations. |
Wellth's mobile platform uses behavioral economics to encourage treatment adherence for payers or employers.
|
| Helium Health | Series A | $10.00 | Global Ventures, Africa Healthcare Masterfund, Tencent, Ohara Pharmaceutical, HOF Capital, Y Combinator, VentureSouq, Chrysalis Capital, Kairos Angels and Flying Doctors Healthcare Investment Company | The startup will use the funding round to grow its current customer base in Nigeria, Ghana and Liberia, as well as to support expansion into new markets in North and East Africa, and French West Africa this year. |
Helium Health is a telehealth and healthcare technology provider in West Africa.
|
| Ultromics | Series A | $10.00 | Oxford Sciences Innovation and Mayo Clinic. | The company said this new infusion of cash will go towards growing its next stage of business growth. |
It is currently focused on creating decision-support tools for the heart health space.
|
| Bigfoot Biomedical | Series C | $10 |
Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.
|
The startup has developed an insulin-delivery system that is able to connect to smartphones and other management devices in order to help with dosing.
|
|
| Ferrum Health | Seed round | $9 | Blumberg Capital, GSR, Vulcan Capital, Valley Capital Partners and "an undisclosed strategic family office" | The new funds will help the startup continue to flesh out its technology, pick up new engineering hires, and expand its sales and marketing efforts. |
Ferrum is building an artificial intelligence platform that aims to spot and prevent medical errors and spot potential cancer diagnoses within the hospital's radiology department.
|
| Limbix | Series A | $9 | GSR Ventures, Sequoia Capital, Storm Ventures, NexGen Venture Partners and BIXINK Therapeutics | The new money will go towards developing Limbix's product and testing it. |
The company is focused on creating a digital mental health tool for teens, and works through a mobile app.
|
| Braid Health | Seed and Series A | $9 | Lux Capital, 01 Advisors and Rucker Park Capital | It plans to use the new funds to hire new team members, continue to build an AI-powered diagnostic platform, and develop a platform that can connect to networks of healthcare providers. |
The company has created a teleradiology platform that combines AI technologies and board-certified radiologists.
|
| Orbita | Series A | $9 | Philips Health Technology Ventures, HealthX Ventures, Cultivation Capital and Newark Venture Partners | The company did not specify how it would use the funds. |
Orbita's technology platform is employed by healthcare, life sciences and medical technology companies seeking conversational AI capabilities that can be deployed through online, phone, text or digital-assistant means.
|
| Mindler | Series A | $9 | Ventech and Schibsted Growth | Mindler plans to use the money to support the development of the platform and open it up to other European markets. |
The startup aims to make psychological help available to whomsoever may require it through its free smartphone app for video CBT.
|
| Endofotonics | N/A | $9 | Tony Tan Choon Keat and Dr. Beng Teck Liang | The funds will be used to drive commercialization of its early gastric cancer detection system, SPECTRA IMDx, in Asia Pacific and to expand the coverage of its cancer detection technology to other organs. |
Endofotonics' SPECTRA IMDx system enables real time detection of early gastric cancer during endoscopy, in part with the support of proprietary AI.
|
| Meru Health | Series A | $8 | Foundry Group, Slack, Bold Capital and Y Combinator | While the company did not specify exactly how the funds will be used, it has been stressing its commitment to furthering research on its product and digital mental health. |
Meru Health offers several different mental health services, including a 12-week tailored content program.
|
| Big Sky Health | Series A | $8 | Greycroft | The new funds will propel the launch of the Zero Plus, the company's new alcohol reduction platform. |
Big Sky Health's main product is focused on helping dieters with their fasting regiment. The app includes a fast timer, as well as a digital journal and statistics.
|
| XRHealth | N/A | $7 | Bridges Israel, Flint Capital and 20/20 HealthCare Partners | The new funds would help expand the new telehealth platform so that it can reach more clinicians and patients during the COVID-19 crisis. |
The startup (formerly VRHealth) has developed a number of health applications for its VR platform, and more recently has dipped into remote care.
|
| Avive Solutions | N/A | $7 | Laerdal Million Lives Fund, Kenko Venture Partners, Irish Angels and other individual investors with healthcare experience | The new funds will help prepare Avive for its commercial launch |
The company develops technologies that integrate with emergency response systems to quickly help those experiencing out-of-hospital sudden cardiac arrest.
|
| Datos Health | Series A | $7 | Crescendo Venture Partners, Industry Ventures, Vertex and Angular Ventures | Datos said that it would be looking to expand its sales and marketing efforts with the new funds. The company is also aiming to beef up its workforce and accelerate development of its workflow-friendly remote-care platform. |
Datos offers an automated remote care and telemedicine platform for hospitals.
|
| Lionrock Recovery | N/A | $7.00 | Wasserstein Family Trust and Big Spruce Holdings | With this raise, the startup aims to further build out its staff, marketing efforts, clinical offerings and proprietary-practice management systems. |
Lionrock Recovery is a telehealth services provider specializing in substance-use disorders.
|
| PatientPay | N/A | $6 | Mosaik Partners | The company plans to use the new funds to grow its product line and expand its services. |
PatientPay focuses on billing services regarding acute, ambulatory and specialty care.
|
| SteadyMD | Series A | $6 | Pelion Venture Partners, Next Ventures, First Trust Capital Partners, the Daube Family Office, Crosscut Ventures, M25, Wild Ventures and Hyde Park Venture Partners | These funds will further develop SteadMD's technology platform and online services. |
The startup's virtual care service connects members to text, phone and video care from board-certified primary care, pediatrics and functional-medicine doctors.
|
| Yes Health | N/A | $6 | Khosla Ventures | The company said it will be expanding its staff, fleshing out its platform and scaling its business. |
Yess Health's chronic disease management platform uses AI to support human coaches.
|
| Cariloop | Series A | $6 | Patterson Thoma Family Office, Revolution's Rise of the Rest Seed Fund, ACAP Health, KCRise Fund, MPK Equity Partners, Patrick McGee and other unnamed existing backers | The new funds will help expand Cariloop's team and accelerate its nationwide strategic distribution efforts. |
Cariloop is a a tech platform that focuses on coaching and cloud-based support tools for caregivers.
|
| TimeDoc | Series A | $5.70 | Vocap Investment Partners, Grand Ventures, Serra Ventures, Waterline Ventures, Impact Engine, Break Trail Ventures, Chaifetz Group and Pat Welsh | The new cash will help the company increase its sales capabilities, deepen its integration with EHRs, enable remote patient-monitoring features and build new tools to improve patient outcomes. |
TimeDoc offers a chronic care population management platform.
|
| Dorsata | Series A | $5 | Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital | Dorsata offers a tool designed to help prevent variations in medical care during maternity and decrease the rate of preventable complications. |
The company plans to use the new funds to integrate Dorsata into new EHR systems and bring the system to new providers and patients.
|
| Calibrate | seed | $5 | led by Forerunner Ventures. | To launch the digital-weight-management startup |
Calibrate is a one-year telemedicine program focused on weight loss that combines both prescription medications and health coaching.
|
| Paige | Series B | $5 | Goldman Sachs | Page plans to put the new money towards growing its diagnostic and testing products. |
The company uses artificial intelligence to help oncologists and pathologists make faster decisions about how to care for cancer patients.
|
| careMESH | seed | $5 | Assurance Capital and Pavey Family Investments. Prior backers in the company also participated. | The Virginia startup said that it would be using the raise to increase adoption of its platform. |
It is the maker of a national provider directory and information sharing platform.
|
| Wellthy Therapeutics | pre-Series A | $4 | Saama Capital | In addition to expanding into new regions, the company said that it will be using these funds to prepare for the launch of its digital respiratory therapeutic portfolio. |
Wellthy is a digital-therapeutics company targeting chronic-disease prevention, management and reversal.
|
| Lucid Lane | Seed funding | $4 | Battery Ventures | The company did not outline specific plans for its seed funding. |
Lucid Lane's patient-facing approach combines regular virtual coaching from licensed therapists and data-driven treatment planning.
|
| Wellsheet | Series A | $4 | SpringTide Investments headed the round, which also saw contributions from BioAdvance and Newark Venture Partners. | The new funds will help his company build up its engineering and go-to-market teams. The money will also allow Wellsheet's platform to expand across platforms. |
Wellsheet is a startup working to streamline EHR workflows via API.
|
| Agamon | seed | $3 | MMC Ventures, with contributions from InHealth Ventures, Seedcamp and Bayer G4A. | The company will be working toward scaling up global hospital deployments of its AI, which it will continue to train so that it can handle a wider range of clinical data. |
It is a Tel Aviv, Israel-based startup using AI to format unstructured clinical data.
|
| Tava Health | Seed funding | $3 | Peterson Ventures | The company said that it will be using these funds to expand the service into new geographic markets. |
Tava works with employer customers to connect their employees with remote mental health therapy and a personalized treatment plan.
|
| Deep01 | N/A | $3 | ASUSTek, and included support from the Digital Economy Fund and BE Capital. | Deep01's software is has been cleared by the FDA, and according to the company is being used in six facilities in Taiwan. The company said that it also received its first purchase order in February. |
It is a CT brain scan analysis software maker.
|
| Ophelia | Seed funding | $3 | General Catalyst, Refactor Capital and Y Combinator | The company did not specify how the new funds would be used. |
Ophelia combines an initial in-person visit and subsequent digital services to support substance abuse recovery.
|
| Stork Club | Seed funding | $3 | Bowery Capital, Slow Ventures and angel investors | The startup did not specify how the funds would be used. |
The concierge platform helps guide women through different phases of the maternity process, including diagnostics, egg and sperm freezing, IVF, surrogacy and adoption, childbirth, and breastfeeding support.
|
| Every Mother | Seed funding | $1.50 | Courtside Ventures, Serena Ventures, Techstar Ventures, The Fund and a handful of angel investors | This raise will help the company grow its service "to meet an ever-growing demand." |
Every Mother's programs target fitness and physical challenges specific to pregnancy – for instance, repairing diastasis recti (ab separation) or relieving back pain and urinary incontinence.
|
| Navenio | N/A | $1 | Innovate UK | The money secured from the Fast Start fund will be used to expand operations of the company’s "Intelligent Workforce Solution." |
Navenio develops infrastructure-free location-based technologies that support apps and digital platforms across various sectors including health.
|
| Aaptiv | N/A | Undisclosed | Insight Partners | The startup said that it will flesh out its enterprise API offering, allowing classes to be played through outside platforms. |
Aaptiv delivers trainer-led fitness workouts and wellness sessions.
|
| CXS Growth | N/A | Undisclosed | Humanica and HSBC | CXA Group further customize its platform from a software engineering perspective, which can then be white-labelled and used separately by each bank in the Asia region and offered to their base of commercial banking clients. |
CXA offers an employee benefits and wellness marketplace.
|
| Swoop Aero | Series A | Undisclosed | Right Click Capital and Tempus Partners | The startup will use the latest eight figure sum capital injection to establish a presence in Australia and New Zealand (ANZ), as well as expand its service offering across the medical logistics space. |
Swoop Aero says it aims to provide one hundred million people with better access to healthcare by 2025.
|
| DocASAP | N/A | Undisclosed | Optum Ventures | It will now be turning its attention toward payer-provider network growth and platform advancement. |
The company is a patient access, engagement and navigation platform
|
